エピソード

  • When Saving Lives Meant Letting Others Die: Helsinki's Moral Rift

    When Saving Lives Meant Letting Others Die: Helsinki's Moral Rift
    2026/10/28
    When Saving Lives Meant Letting Others Die: Helsinki's Moral Rift

    A single phrase in an eleven-paragraph document shifted consent from "absolutely" to "to the fullest extent possible," letting proxy consent and placebo trials move from rare exceptions into global practice - and by the late 1990s geography alone was deciding who received life-saving treatments. How did a declaration with no legal teeth end up governing experiments that let some women receive a drug that cut mother-to-child HIV transmission by nearly 70% while others got placebo?

    In this episode, we lay out the decisions, clauses, and institutional choices that connected Nuremberg to Helsinki to AIDS trials in the 1990s, and ask whether professional consensus can ethically substitute for law when lives are at stake.

    Person: Twenty-three German physicians
    Date: June 1964
    Document: Declaration of Helsinki (eleven paragraphs)
    Study: AIDS Clinical Trials Group Study 076 (Zidovudine)
    Result: nearly 70% reduction in mother-to-child HIV transmission

    - Nuremberg Tribunal produced the Nuremberg Code with ten principles in 1947.
    - Helsinki replaced the Nuremberg Code's "absolutely essential" consent with "to the fullest extent possible" in June 1964.
    - The 1975 Tokyo revision of Helsinki introduced independent protocol-review committees and prioritized subjects' interests over science.
    - The 1994 Zidovudine trial (Study 076) showed nearly 70% reduction in maternal HIV transmission.
    - The FDA adopted the 1996 version of Helsinki, allowing placebo where "no proven method existed," while ignoring later revisions.

    To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

    © 2026 OBOMEDIA. All rights reserved.
    This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
    続きを読む 一部表示
    21 分
  • The Marshmallow Lie: How One Room Sold Willpower as Destiny

    The Marshmallow Lie: How One Room Sold Willpower as Destiny
    2026/10/27
    The Marshmallow Lie: How One Room Sold Willpower as Destiny

    The idea that a fifteen-minute test in a small Stanford room could predict your whole life still grips audiences: the marshmallow parable claimed kids who waited scored about 210 points higher on the SAT and were later rated more competent, but that sweeping lesson was drawn from just fifty children from one privileged nursery-so what did the experiment actually measure, and who did it leave out?

    In this episode, we present the original setup, the follow-up findings, and the overlooked details that changed the meaning of the study; you’ll hear how the room, the tin, and the bell shaped behavior-so was the test measuring innate self-control or something else?

    Person: Walter Mischel
    Date: 1972
    Location: Stanford University (Bing Nursery School)
    Sample size: 50 children (6 excluded from analysis)
    Follow-up year: 1990 (SAT score comparison)

    - The original experiment included children aged 3 years 6 months to 5 years 6 months, with a median age of 4 years 6 months.
    - Fifty children participated in the first sub-experiment; six were excluded from the analysis.
    - High delayers scored on average about 210 points higher on the SAT than low delayers in the 1990 follow-up.
    - The experiment used an opaque cake tin containing one marshmallow and one pretzel stick, with a desk bell on the table as the surrender instrument.
    - A 1970 experiment found that when rewards were visible, children waited less, so the 1972 study deliberately hid the treat to increase waiting.

    To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

    © 2026 OBOMEDIA. All rights reserved.
    This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
    続きを読む 一部表示
    20 分
  • The Man Who Flipped 450V: Why Ordinary People Obeyed

    The Man Who Flipped 450V: Why Ordinary People Obeyed
    2026/10/26
    The Man Who Flipped 450V: Why Ordinary People Obeyed

    The basement device at Yale had thirty switches rising to 450 volts, and when tested in 1961, 65% of ordinary people delivered the highest shock - yet every participant had passed 300 volts first. What hidden detail discovered in 2012 complicates the story and raises the question: what did Milgram never make public?

    In this episode, we present the original setup, procedure, and startling results of the Yale obedience study, and introduce the later re-examination of the data that challenges the simple reading of those numbers. How does that undisclosed finding change what we thought we knew about obedience?

    Person: Stanley Milgram
    Date: 1961
    Location: Yale University basement
    Event: Obedience to authority experiment with shock generator
    Author: Gina Perry (re-examination in 2012)

    - The shock generator had thirty switches in a horizontal row, increasing in 15-volt increments from 15V to 450V.
    - Final three switches were unlabeled and marked only with "XXX" without voltage descriptions.
    - Fourteen of the first forty subjects laughed nervously during the sessions; Milgram recorded this laughter as distress.
    - Every participant who continued had already delivered at least 300 volts before proceeding further.
    - The experiment included one real 45-volt sample shock administered to the teacher before the session began.

    To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

    © 2026 OBOMEDIA. All rights reserved.
    This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
    続きを読む 一部表示
    21 分
  • Researchers who enroll patients in clinical trials - only 24% would enroll themselves

    Researchers who enroll patients in clinical trials - only 24% would enroll themselves
    2026/10/25
    Researchers who enroll patients in clinical trials - only 24% would enroll themselves

    Fewer than one in four rural physicians and research coordinators surveyed in 2015 said they would personally enroll in a clinical trial, despite obtaining consent from patients every week - what does that gap between practice and personal choice reveal about informed consent and the system that depends on it? Could decades of ethical failures and uneven training explain why many who obtain consent for others refuse it for themselves?

    In this episode, we trace a path from a 2015 University of Montana survey to the postwar origins of modern research ethics, laying out what the study measured and why the findings matter for everyday clinical practice - can informed consent mean the same thing when those who administer it are reluctant to accept it?

    Person: Ann Cook and Freeman Hoas
    Date: 2015
    Location: rural America; University of Montana Department of Psychology
    Sample size: 80 respondents
    Setting: hospital or hospital-clinic for 90% of respondents

    - 24% of respondents said they would personally enroll in a clinical trial, and only with conditions.
    - 34 of the 80 respondents were physicians or active researchers.
    - 46 of the 80 respondents were research coordinators.
    - 66% of research coordinators reported some research methods training; 53% of physicians reported the same.
    - 59% of coordinators had ethics training versus 17% of physicians.

    To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

    © 2026 OBOMEDIA. All rights reserved.
    This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
    続きを読む 一部表示
    21 分
  • The Doctor's Touch: How Trusted Hands Hid Decades of Abuse

    The Doctor's Touch: How Trusted Hands Hid Decades of Abuse
    2026/10/24
    The Doctor's Touch: How Trusted Hands Hid Decades of Abuse

    Trust turned to betrayal: a doctor with peer‑reviewed papers, university credentials, and access to Olympic champions abused at least 265 girls over decades while parents sat in the corner believing they were watching treatment. How did documented warnings sent as early as 1997 land on desks and lead to eighteen more years of harm before accountability arrived?

    In this episode, we tell the documented timeline of Lawrence Gerard Nassar’s career, the reported abuse inside treatment rooms and at the Karolyi Ranch, and the institutional warnings that followed - asking how so many systems failed the athletes they were meant to protect.

    Person: Lawrence Gerard Nassar
    Date of birth: August 16, 1963
    Number of victims testified: more than 265
    Earliest reported abuse date in record: 1994
    First documented institutional warning received: 1997

    - He earned a Bachelor of Science in Kinesiology from the University of Michigan in 1985 and a Doctor of Osteopathic Medicine at Michigan State University in 1993.
    - He completed a sports medicine fellowship and joined MSU’s College of Osteopathic Medicine as an assistant professor in 1997 with an approximate annual salary of $100,000.
    - He began working as an athletic trainer for the national team in 1986 and was National Medical Coordinator for USA Gymnastics from 1996 to 2014.
    - Victim testimony describes an intrapelvic pressure‑point technique involving an ungloved vaginal finger insertion without informed consent, with the earliest victim‑stated date about 1992 and the earliest recorded date 1994.
    - He practiced at the Karolyi Ranch in Huntsville, Texas, despite not holding a Texas medical license, which is a third‑degree felony.

    To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

    © 2026 OBOMEDIA. All rights reserved.
    This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
    続きを読む 一部表示
    22 分
  • First Patient: How a Trauma Trial Betrayed Meaghan Buisson

    First Patient: How a Trauma Trial Betrayed Meaghan Buisson
    2026/10/23
    First Patient: How a Trauma Trial Betrayed Meaghan Buisson

    She was an elite athlete who once broke the solo marathon world record on inline skates, and she became the very first patient at a clinical trial for MDMA-assisted psychotherapy-only to be harmed inside it. How did a trial designed to treat trauma allow a therapist with a lapsed license to cross boundaries that Canadian law classifies as sexual abuse?

    In this episode, we tell the story of Meaghan Buisson and what happened during her enrollment in a MAPS-sponsored MDMA-assisted psychotherapy trial, including the protocol, the therapists involved, the timeline of her participation, and the events that followed-did the trial protect its first patient?

    Person: Meaghan Buisson
    Organization: MAPS (Multidisciplinary Association for Psychedelic Studies)
    Therapists: Richard Yensen and Donna Dryer
    Enrollment date: December 2014
    Final formal enrollment end: June 2016

    - She skated to a solo marathon world record and received a speeding ticket for inline skating in 2006.
    - She won forty-seven Canadian national championships, set sixteen Canadian records, and earned eleven international medals.
    - She enrolled as the first patient at her trial site in December 2014 and began sessions under the trial protocol.
    - Richard Yensen’s psychology license had lapsed in 2009, five years before Buisson became his patient.
    - A sexual relationship between Buisson and Yensen began between October 2015 and early 2016 while she was still an active trial participant.

    To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

    © 2026 OBOMEDIA. All rights reserved.
    This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
    続きを読む 一部表示
    18 分
  • They Read the Reports - Let Two Thousand Bleed Quietly

    They Read the Reports - Let Two Thousand Bleed Quietly
    2026/10/22
    They Read the Reports - Let Two Thousand Bleed Quietly

    They kept vials of clotting factor concentrates in home refrigerators like insulin, but internal ministry files show officials read warnings about contaminated blood and chose not to act. Around two thousand of Japan's roughly 4,500 haemophiliacs contracted HIV in the 1980s-so who decided to keep the heat‑treated, safer product off the market, and why?

    In this episode, we lay out the sequence recorded in ministry and corporate documents: the arrival of a heat‑treated product from Baxter Travenol, a one‑week reversal of a committee recommendation to ban untreated imports, and the ties between regulators and industry that shaped the decision. What did the internal reports say, who read them, and how did those choices translate into infections?

    Person: Green Cross Corporation executives and Ministry bureaucrats
    Topic: HIV infections among haemophiliacs linked to blood products
    Date: 1979-1986 (first known infection 1979; key events 1981-1983)
    Location: Japan
    Event: Withdrawal of committee recommendation within one week to ban untreated imports

    - Approximately 2,000 of Japan's ~4,500 haemophiliacs contracted HIV during the 1980s.
    - Baxter Travenol notified Japan's Ministry in 1983 that it had an FDA‑licensed heat‑treated clotting factor.
    - The ministry committee recommended banning untreated imports and emergency licensing of the heat‑treated product, then formally withdrew that recommendation within one week.
    - At least nine former Ministry bureaucrats took executive roles in Japan's blood products companies (amakudari pattern).
    - Japan imported tens of millions of units of clotting factor concentrate and millions of litres of plasma in the late 1970s-early 1980s.

    To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

    © 2026 OBOMEDIA. All rights reserved.
    This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
    続きを読む 一部表示
    21 分
  • - it should not have been wrong. 88 children died

    - it should not have been wrong. 88 children died
    2026/10/21
    - it should not have been wrong. 88 children died

    The number carved on a drum promised "Ninety-eight percent USP-grade glycerine"-a pharmaceutical guarantee measured to decimal points-but the barrel actually contained 54% glycerine and a large proportion of diethylene glycol, a colorless, odorless poison that killed 88 Haitian children within days; how did a written laboratory warning fail to stop those deaths, and was this an accident or part of a decades-long mechanism that repeated around the world?

    In this episode, we lay out the chain of documents, decisions, and shipments that led from a Chinese supplier to a Dutch trader to a Haitian manufacturer to sick children, and follow parallel signs that the same lethal substitution surfaced later in other countries; could a single withheld warning explain eighty-eight deaths in Haiti and more elsewhere?

    Person: Dr. Michael Bennish
    Event: Haiti pediatric syrup poisoning
    Country: Haiti
    Date: 1996
    Substance: 54% glycerine and substantial diethylene glycol

    - 109 children swallowed the contaminated syrups Afébril and Valodon.
    - 88 children died, a case fatality rate of over 80%.
    - Laboratory analysis showed the drum contained 54% glycerine, not 98% as labeled.
    - A laboratory had warned Vos BV the batch was impure before shipment, but Vos BV did not pass the warning to Pharval.
    - Vos BV later settled a Dutch environmental case in 2001 for 500,000 guilders with no homicide prosecution.

    To listen to this podcast ad-free and access premium episodes, try our subscription with a 14-day free trial at obomedia.com.

    © 2026 OBOMEDIA. All rights reserved.
    This episode and its content (audio, text, and related materials) are the exclusive property of OBOMEDIA and are protected by applicable copyright laws. Reproduction, distribution, editing, or commercial use, in whole or in part, without prior written permission from OBOMEDIA is prohibited. For permissions, licensing, and business inquiries: business@obomedia.com.
    続きを読む 一部表示
    21 分